 Morphine-induced transactivation LTR human neuroblastoma cells Infection human immunodeficiency virus HIV many cases quiescent latent phase host antiviral defense intact possibility certain host susceptibility factors environmental cofactors progression disease study morphine HIV/LTR-CAT fusion gene HIV-long terminal repeat-chloramphenicol acetyltransferase undifferentiated human neuroblastoma cells stimulatory effect morphine cells first phorbol PMA cells retinoic acid RA Morphine HIV/LTR-CAT expression human cells Morphine activation HIV/LTR-CAT cells reversible naltrexone Fos/Jun signaling system results narcotics morphine activation latent HIV infection important tissues brain latent HIV infection patients acquired immunodeficiency syndrome AIDS neuronal degeneration dementia findings important implications pathogenesis AIDS opiate drug abusers